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Materials and Methods

-Glucosidase type I (G 5003), rat-intestinal acetone powder (I 1630), p-nitrophenyl-α-D-
glucopyranoside (N 1377, ≥ 99%), butylhydroxytoluene (BHT. B1378, ≥ 99%), α-tocopherol (T 3251, ≥ 95%), quercetin (Q 0125, ≥ 98%), acarbose (A 8980, ≥ 95%), 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical (D 21,140-0, ≥ 95%), streptomycin (S9137), chloramphenicol (C0378, ≥ 98%), amphotericin B (A2942), and 1,1,3,3-tetramethoxypropane (108 383, ≥ 99%) were purchased from Sigma-Aldrich. Ampicillin (IBI02040) was purchased from IBI Scientific and thiobarbituric acid (190284, 98%) from ICN. Hinton broth without compounds and 10 µL of the inocula were used as a negative control.
Antimicrobial activities
Each well with compounds was inoculated with 10 µL of diluted bacterial suspension to a final concentration of 5 × 10 5 CFU mL -1 . All plates were incubated at 37°C for 18 h. 100, where AC is the absorbance of the negative control and AS is the absorbance of the tested sample. All samples were tested in triplicate.
Mammalian α-glucosidase inhibition assay
The mammalian α-glucosidase was prepared following the modified method of Jo et al.
[21]. Rat intestinal acetone powder (100 mg) was rehydrated with 4 mL of 67 mM ice-cold phosphate buffer (pH 6.8) and homogenized for 3 min at 4°C. 
Table S1
1 H NMR data of compounds 1-5 (DMSO-d 6 , 500 MHz). 1.14 d (7.5) (13.6, 12.0, 9.2) 1.73 ddd (13.5, 11.5, 9.0) 1.99 ddd (14.0, 10.5, 8.0) 1.73 ddd (13.5, 12.0, 9.0) 
